VYCOR MEDICAL INC Cash Flow Statement
VYCO|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
VYCOR MEDICAL INC used $13,471 in operating cash flow and negative free cash flow of $18,695 in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -35.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$72.4K | -$107.2K | -$69.7K | -$404.9K | -$435.7K | -$822.5K | -$796.2K | -$1.4M | -$1.5M | -$1.7M | -$2.1M | -$4.0M | -$2.4M | -$2.9M | -$4.8M |
| Depreciation & Amortization | $59.5K | $59.5K | $57.5K | $58.2K | $66.1K | $56.5K | $59.9K | $166.4K | $275.4K | $257.6K | $360.3K | $368.6K | $350.5K | $328.9K | $210.0K |
| Operating Cash Flow | -$13.5K | $60.1K | $29.4K | -$217.0K | $21.4K | -$248.8K | -$6.0K | -$260.3K | -$527.4K | -$496.9K | -$1.2M | -$2.7M | -$758.4K | -$1.4M | -$3.2M |
| Capital Expenditures | $5.2K | $5.4K | $9.4K | $2.8K | $38.4K | $62.1K | $52.9K | $63.5K | $183.3K | $57.5K | $210.0K | $130.8K | $128.1K | $28.2K | $62.0K |
| Free Cash Flow | -$18.7K | $54.7K | $20.0K | -$219.8K | -$17.0K | -$310.8K | -$58.9K | -$323.8K | -$710.7K | -$554.4K | -$1.4M | -$2.8M | -$886.5K | -$1.4M | -$3.3M |
| FCF Margin | -1.0% | 3.4% | 1.4% | -18.0% | -1.2% | -27.2% | -4.2% | -21.5% | -51.3% | -38.2% | -121.0% | -226.5% | -81.4% | -116.1% | -335.3% |